New research by a Florida State Univ. chemistry professor uses some of the world’s most powerful magnets to put a bullseye on the flu virus.
Led by Prof. of Chemistry & Biochemistry Tim Cross and his team at the Florida State Univ.-based National High Magnetic Field Laboratory, scientists delved into the complexities of exactly how the flu virus works and why it’s so effective at making people so sick. With a better understanding of how it works, researchers will now be able to turn their attention to creating more effective prescription drugs to fight the flu.
Cross and his team were able to detail the mechanism that activates the flu virus permitting it to reproduce in a human cell. They laid out their findings in Structure.
“If we can get a drug that disrupts this mechanism, that would be huge,” Cross said. “We really don’t know when a deadly flu epidemic is going to hit next. We need backup to vaccines.”
But to create those drugs, scientists needed to first understand how the virus functions on its most basic level.
The influenza virus is what’s known as an enveloped virus, meaning it has a membrane coat, similar to the way a cell has a membrane. In that membrane are three different proteins, one of which is called the M2 proton channel.
As the virus moves into a cell, it enters an acidic environment, which activates the M2 proton channel. Once the M2 proton channel is activated, protons move through the channel and compel the membrane coat to fuse to the host membrane, causing infection and ultimately, reproduction of the virus.
Using the National MagLab’s most sensitive nuclear magnetic resonance magnet—essentially a super powered MRI—scientists were able to get a clear image of the channel and how protons moved through it causing the fusion of the virus with the host membranes.
“We can actually see the protons move,” Cross said. “Nobody thought we would be able to do this.”
For years, scientists worldwide have been fixated on how this channel works because it provides the basic clues to understanding how viral infection works. The M2 channel has long been a target of drug developers, but when the swine flu broke out in 2009, doctors quickly discovered that drugs that had been in use for decades suddenly didn’t work.
“The drugs didn’t work anymore,” Cross said. “As in so many cases, the virus had evolved. So, there’s a lot of interest in studying this protein and seeing if we can develop a new antibiotic.”
Source: Florida State Univ.
• CONFERENCE AGENDA ANNOUNCED:
The highly-anticipated educational tracks for the 2015 R&D 100 Awards & Technology Conference feature 28 sessions, plus keynote speakers Dean Kamen and Oak Ridge National Laboratory Director Thom Mason. Learn more.
